文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

壳聚糖基纳米复合物的疏水性修饰程度对依诺肝素口服传递的探索。

Exploration of hydrophobic modification degree of chitosan-based nanocomplexes on the oral delivery of enoxaparin.

机构信息

School of Pharmacy, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenyang 110016, China.

出版信息

Eur J Pharm Sci. 2013 Nov 20;50(3-4):263-71. doi: 10.1016/j.ejps.2013.07.009. Epub 2013 Jul 26.


DOI:10.1016/j.ejps.2013.07.009
PMID:23896170
Abstract

The objective of this paper is to elucidate the influence of lipophilic modification degree of chitosan on the peroral absorption of enoxaparin. A series of novel chitosan grafted glyceryl monostearate (GM) copolymers with different GM substitution degree were synthesized and the successful synthesis was confirmed by (1)H NMR, FTIR and X-ray diffraction. Enoxaparin loaded nanocomplexes with different carriers were prepared by self-assembly process. Influence of GM substitution degree and chitosan molecular weight in the copolymer on the properties of the nanocomplexes was investigated. Morphology of the nanocomplexes was observed by atomic force microscopy. Mucoadhesive properties of the nanocomplexes were characterized using mucin particle method. Initially, mucoadhesion of the nanocomplexes increased with the increase of GM substitution degree and it started to decrease when the substitution degree was up to 18.6%. A good linear relationship between GM substitution degree and in vivo absorption of enoxaparin in fasted rats was established in the substitution degree range of 0-11.1%. In agreement with mucoadhesion data, further increasing GM substitution degree to 18.6% caused a decrease in oral absorption. In conclusion, oral bioavailability of enoxaparin can be enhanced by structure modification of the carriers and the bioavailability is hydrophobic modification degree dependent.

摘要

本文旨在阐明壳聚糖的疏水性修饰程度对依诺肝素口服吸收的影响。合成了一系列具有不同 GM 取代度的新型壳聚糖接枝甘油单硬脂酸酯(GM)共聚物,并通过(1)H NMR、FTIR 和 X 射线衍射证实了其成功合成。通过自组装工艺制备了具有不同载体的依诺肝素载纳米复合物。考察了 GM 取代度和共聚物中壳聚糖分子量对纳米复合物性质的影响。通过原子力显微镜观察了纳米复合物的形态。通过粘蛋白颗粒法研究了纳米复合物的粘膜粘附性能。首先,纳米复合物的粘膜粘附性随 GM 取代度的增加而增加,当取代度达到 18.6%时开始下降。在 0-11.1%的取代度范围内,建立了 GM 取代度与依诺肝素在禁食大鼠体内吸收之间的良好线性关系。与粘膜粘附数据一致,进一步将 GM 取代度增加到 18.6%会导致口服吸收减少。总之,通过载体的结构修饰可以提高依诺肝素的口服生物利用度,且生物利用度与疏水性修饰程度有关。

相似文献

[1]
Exploration of hydrophobic modification degree of chitosan-based nanocomplexes on the oral delivery of enoxaparin.

Eur J Pharm Sci. 2013-7-26

[2]
In vitro and in vivo evaluation of chitosan graft glyceryl monooleate as peroral delivery carrier of enoxaparin.

Int J Pharm. 2014-8-25

[3]
Uptake, transport and peroral absorption of fatty glyceride grafted chitosan copolymer-enoxaparin nanocomplexes: influence of glyceride chain length.

Acta Biomater. 2014-5-9

[4]
Bioadhesion and oral absorption of enoxaparin nanocomplexes.

Int J Pharm. 2009-12-1

[5]
Chitosan based polymer-lipid hybrid nanoparticles for oral delivery of enoxaparin.

Int J Pharm. 2018-6-1

[6]
Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.

Int J Pharm. 2013-8-29

[7]
Self-assembled polyelectrolyte nanocomplexes between chitosan derivatives and enoxaparin.

Eur J Pharm Biopharm. 2008-6

[8]
Enhanced oral insulin delivery via surface hydrophilic modification of chitosan copolymer based self-assembly polyelectrolyte nanocomplex.

Int J Pharm. 2018-10-29

[9]
Chitosan nanoconstructs for improved oral delivery of low molecular weight heparin: In vitro and in vivo evaluation.

Int J Pharm. 2011-11-3

[10]
Polymeric micelles of amphiphilic graft copolymer of α-tocopherol succinate-g-carboxymethyl chitosan for tamoxifen delivery: Synthesis, characterization and in vivo pharmacokinetic study.

Carbohydr Polym. 2016-6-18

引用本文的文献

[1]
Advanced delivery strategies facilitating oral absorption of heparins.

Asian J Pharm Sci. 2020-7

[2]
Development of Lipid-Polymer Hybrid Nanoparticles for Improving Oral Absorption of Enoxaparin.

Pharmaceutics. 2020-6-30

[3]
Functionalized Polymers for Enhance Oral Bioavailability of Sensitive Molecules.

Polymers (Basel). 2016-6-2

[4]
Low-Molecular-Weight Heparins: Reduced Size Particulate Systems for Improved Therapeutic Outcomes.

Molecules. 2018-7-18

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索